Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
| Image |  |
|---|---|
| Description | scientific article published on 11 May 2010 |
| Author/s |
author: Ian Kerridge David J Gottlieb |
| Publication date | May 11, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |